Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
The following recommendations synthesize clinical trial protocols with practical considerations for Canadian users
Brightens overall: This process clears away dullness, revealing brighter, more radiant, and luminous skin
* A premium powder of decolorized inner leaf aloe to support a healthy intestinal lining
.jpg)
